GENEVA, Sept. 18 -- MAINEHEALTH filed a patent application (US2026/018002) for “CTHRC1 IS A NOVEL IMMUNE CHECKPOINT MOLECULE IN COLORECTAL CANCER”. With publication no. WO/2026/188094, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/18
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....